TUESDAY, DECEMBER 6, 2016

GlaxoSmithKline reports positive results in Phase 1 trial of potential Ebola vaccine

A potential Ebola vaccine developed by GlaxoSmithKline in partnership with the National Institutes of Health (NIH) showed promise during recent Phase 1 clinical testing. Read More »

Free HPV vaccination program a success

The free human papillomavirus vaccination (HPV) program in Europe, offered from Aug. 2012 until the end of 2013, saw the percentage of those who got the vaccine skyrocket from 17 percent to a whopping 75 percent. Read More »

Scientists sequence genomes from malaria-carrying mosquitoes

A team of international scientists has sequenced the genomes from 16 Anopheles mosquito species to better understand the insects and hopefully create a more effective treatment for malaria. Read More »

Avian influenza case confirmed in Guangdong, China

A 31-year-old woman from Dongguan in the Guangdong Province of China, was recently diagnosed with avian influenza A(H7N9), Hong Kong's Centre for Health Protection of the Department of Health (DH) announced on Friday. Read More »

Mylan enters agreement with Gilead to develop new HIV drug

Mylan Laboratories Limited reached an agreement with Gilead Sciences Inc. on Monday to manufacture and distribute Tenofovir Alafenamide, an experimental HIV medication. Read More »

Xpert Norovirus test gets green light from FDA

Cepheid, a molecular diagnostics company, recently received clearance from the U.S Food and Drug Administration to market its Xpert Norovirus test. Read More »

MeadWestvaco receives grant for MEMS use in HIV/AIDS fight

MeadWestvaco Corporation (MWV) recently received a grant to provide the Bill & Melinda Gates Foundation with its Medication Event Monitoring System (MEMS) for use in a project to help prevent the spread of HIV/AIDS in Africa and India. Read More »

ABIVAX successfully tests AIDS drug on humans

ABIVAX, a clinical stage biotechnology company, recently completed a successful first-in-man Phase 1 study of ABX464, which may prevent the replication of the virus that causes AIDS. Read More »

Walgreens releases data showing flu rates

Walgreens (NYSE: WAG) (Nasdaq: WAG) recently released weekly data from its Flu Index that reveals specific areas within the United States where the flu is escalating the most. The data rates areas based on the number of influenza cases throughout the United States as well as the accumulative rate of cases from week to week. Read More »

MERS-CoV study directed at health care workers

Greek researchers recently were able to identify gaps in infection control as a probable cause in all 11 known cases involving health care-associated transmission of Middle East respiratory syndrome coronavirus (MERS-CoV). Read More »

FDA approves Sanofi Pasteur’s supplemental biologics license

The United States Food and Drug Administration (FDA) recently approved a supplemental biologics license application for Sanofi Pasteur’s new Fluzone® High-Dose influenza vaccine. Read More »

STC to work with Alberta Health to control vaccine inventory

Management and distribution of vaccine supply, which can be extremely critical during a pandemic, outbreak, or in the event of a product recall, can be downright chaotic. Read More »

Aethlon reports positive results in Hepatitis C study

Aethlon Medical, Inc. said on Monday that its study conducted on Hepatitis C-infected individuals in India who received Hemopurifier therapy showed promise and the company is now set to start its first human clinical studies in the U.S. Read More »

CDC awards grant to Meridian for rotavirus vaccine

The U.S. Centers for Disease Control and Prevention recently awarded a second Small Business Innovation Research contract to Meridian Life Science, Inc. to create a rotavirus vaccine. Read More »

First human subject receives Bavarian Nordic’s Ebola vaccine

The first human subject in a Phase 1 clinical study for a potential Ebola vaccine recently received a booster dose of Bavarian Nordic's MVA-BN Filo vaccine. Read More »

Another avian influenza case confirmed in Fujian, China

Department of Health (DH) officials in Hong Kong are closely monitoring a patient diagnosed with avian influenza A(H7N9) in Fujian, China, on Wednesday. Read More »

NC State researchers map human diseases

North Carolina State University researchers who recently mapped disease-causing pathogens found the world can theoretically be separated into seven regions for vectored human diseases spread by pests, such as malaria, and five regions for non-vectored diseases, such as cholera. Read More »

Australian researchers find potential new ways to combat malaria

Researchers from Australian National University (ANU) said recently that they discovered a slew of new chemicals with anti-malarial properties that may open the door to develop new drugs to fight the disease. Read More »

Study clarifies children at risk for influenza complications

Researchers at the University of Oxford called on the United States, United Kingdom and the World Health Organization recently to add children born prematurely to the priority group for the seasonal flu vaccine. Read More »

Three influenza strains in Iowa

The Iowa Department of Public Health (IDPH) said on Tuesday that A(H3N2), A(H1N1) and B - all three of the influenza strains in this year’s vaccine - are at large in Iowa. Read More »